Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,807.20
-20.30 (-1.11%)
Nov 12, 2026, 3:29 PM IST
Aurobindo Pharma Stock Forecast
Stock Price Forecast
According to 27 analysts polled by S&P Global, Aurobindo Pharma stock has a consensus rating of "Buy" and an average price target of ₹1,856. The average 1-year stock price forecast is 2.70% higher than the current stock price, while the lowest is ₹1,270 (-29.73%) and the highest is ₹2,195 (+21.46%).
Price Target: ₹1,856 (+2.70%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aurobindo Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 13 | 13 | 13 | 12 | 12 |
| Buy | 6 | 6 | 5 | 5 | 5 | 7 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 2 | 2 | 2 | 2 | 2 | 1 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 28 | 28 | 27 | 27 | 26 | 27 |
Financial Forecast
Revenue This Year
402.49B
from 336.53B
Increased by 19.60%
Revenue Next Year
448.75B
from 402.49B
Increased by 11.49%
EPS This Year
80.86
from 61.11
Increased by 32.32%
EPS Next Year
95.57
from 80.86
Increased by 18.19%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.